Allergan, Celgene Offer Solid Biotech Value

The first five months of 2017 were dominated by the so-called FAANG stocks. A month ago, these five stocks accounted for just over 40% of the Nasdaq's approximate 20% gain for 2017. Investors were willing to pay a large premium to purchase the big, steady growers in the market, especially with the first quarter's anemic GDP growth rate.

That situation has started to change over the past month as some of the momentum has left the FAANG portion of the market and flowed into other sectors of equities. With GDP growth set to pick up significantly over the final three quarters of 2017, I think that rotation will continue....457 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.

Read the full story and get access to the Real Money Pro trading floor.

There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.

Already a Subscriber? Please login.

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.